A detailed history of Bessemer Group Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bessemer Group Inc holds 52 shares of IONS stock, worth $2,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52
Previous 52 -0.0%
Holding current value
$2,064
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$33.58 - $41.2 $906 - $1,112
27 Added 108.0%
52 $2,000
Q4 2022

Feb 13, 2023

BUY
$37.12 - $46.52 $927 - $1,163
25 New
25 $1,000
Q2 2022

Aug 10, 2022

SELL
$31.71 - $43.0 $28,539 - $38,700
-900 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$34.54 - $47.25 $4,455 - $6,095
-129 Reduced 12.54%
900 $36,000
Q1 2021

May 13, 2021

BUY
$42.51 - $63.78 $5,483 - $8,227
129 Added 14.33%
1,029 $46,000
Q4 2019

Feb 04, 2020

SELL
$53.85 - $65.27 $2,692 - $3,263
-50 Reduced 5.26%
900 $54,000
Q2 2019

Jul 19, 2019

BUY
$62.09 - $86.14 $3,104 - $4,307
50 Added 5.56%
950 $61,000
Q1 2018

May 10, 2018

SELL
$44.08 - $55.05 $15,075 - $18,827
-342 Reduced 27.54%
900 $40,000
Q3 2017

Nov 03, 2017

BUY
$45.56 - $59.57 $56,585 - $73,985
1,242
1,242 $63,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.